Axogen (AXGN) Asset Writedowns and Impairment (2016 - 2026)
Axogen has reported Asset Writedowns and Impairment over the past 11 years, most recently at -$120000.0 for Q1 2026.
- For Q1 2026, Asset Writedowns and Impairment fell 164.17% year-over-year to -$120000.0; the TTM value through Mar 2026 reached $93000.0, down 84.02%, while the annual FY2025 figure was $400000.0, 38.46% down from the prior year.
- Asset Writedowns and Impairment for Q1 2026 was -$120000.0 at Axogen, down from $42000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $789000.0 in Q3 2023 and troughed at -$120000.0 in Q1 2026.
- A 5-year average of $253882.4 and a median of $255000.0 in 2024 define the central range for Asset Writedowns and Impairment.
- Biggest five-year swings in Asset Writedowns and Impairment: soared 576.09% in 2023 and later tumbled 164.17% in 2026.
- Year by year, Asset Writedowns and Impairment stood at $46000.0 in 2022, then soared by 576.09% to $311000.0 in 2023, then tumbled by 85.21% to $46000.0 in 2024, then fell by 8.7% to $42000.0 in 2025, then plummeted by 385.71% to -$120000.0 in 2026.
- Business Quant data shows Asset Writedowns and Impairment for AXGN at -$120000.0 in Q1 2026, $42000.0 in Q4 2025, and -$28000.0 in Q3 2025.